Reproductive surgery

Dresner Partners Advised RADfertility in Its Sale to CCRM Fertility

Retrieved on: 
Tuesday, December 6, 2022

CHICAGO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised RADfertility in its sale to CCRM Fertility.

Key Points: 
  • CHICAGO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised RADfertility in its sale to CCRM Fertility.
  • CCRM Fertility is a global pioneer in fertility treatment, research and science.
  • The synergies between the two organizations will further enhance and expand the reach of the CCRM network.”
    Steven M. Dresner, President of Dresner Partners added, “We are very pleased that we were able to help RADfertility find a strategic partner in CCRM Fertility.
  • There is tremendous opportunity for providers to combine their resources to meet their long-term growth objectives.”
    Dresner Partners is a leading provider of investment banking services to the fertility (IVF) sector, having closed numerous transactions including the sale of IGENOMIX, the merger of RMA NJ and IVI of Spain, the sale of Advanced Fertility of Chicago to Prelude Fertility, the sale of Santa Monica Fertility to Webster Equity Partners, the sale of In Via Fertility to InVitro Sciences (now First Fertility), the sale of Institute for Human Reproduction to Pinnacle Fertility, the sale of Dominion Fertility to Pinnacle Fertility, the sale of Center of Reproductive Medicine to US Fertility, the sale of IVF1 to Pinnacle Fertility, the sale of Fertility Institute of New Jersey & New York to Axia Women’s Health, and the sale of RADfertility to CCRM Fertility.

INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo

Retrieved on: 
Tuesday, November 1, 2022

SARASOTA, Fla. and ANAHEIM, Calif., Nov. 1, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell ® medical device and the intravaginal culture ("IVC") procedure it enables, today announced a successful showcasing of INVOcell at last week's 2022 Scientific Congress & Expo of the American Society for Reproductive Medicine (ASRM) held on October 22-26, 2022 in Anaheim, California.

Key Points: 
  • Important to the recent progress, over the past year, INVO Bioscience opened, in collaboration with physician partners, three North American-based INVO Centers focused on offering IVC as an advanced and affordable alternative to IVF, utilizing INVOcell.
  • The ASRM Scientific Congress & Expo, https://www.asrm.org , is an in-person conference held each October in various cities across the U.S.
  • The Society is dedicated to the advancement of the science and practice of reproductive medicine.
  • This year's Congress featured tracks for Reproductive Endocrinology, Assisted Reproductive Technology, ART Lab, Reproductive Surgery, Mental Health, Nursing, Genetic Counseling, Male Reproduction, and more.

INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo

Retrieved on: 
Monday, October 17, 2022

The ASRM Scientific Congress & Expo is an in-person conference held each October in various cities across the U.S.

Key Points: 
  • The ASRM Scientific Congress & Expo is an in-person conference held each October in various cities across the U.S.
  • The Society is dedicated to the advancement of the science and practice of reproductive medicine.
  • This year's Congress features tracks for Reproductive Endocrinology, Assisted Reproductive Technology, ART Lab, Reproductive Surgery, Mental Health, Nursing, Genetic Counseling, Male Reproduction, and more.
  • Our primary mission is to implement new medical technologies aimed at increasing the availability of affordable, high-quality, patient-centered fertility care.

AAGL to Offer an Extensive Lineup of Postgraduate and Continuing Medical Education Courses for the 50th Annual Global Congress on Minimally Invasive Gynecologic Surgery

Retrieved on: 
Friday, October 15, 2021

The Scientific Program at AAGL annual meetings are always meticulously developed and are renowned for offering the best in MIGS education.

Key Points: 
  • The Scientific Program at AAGL annual meetings are always meticulously developed and are renowned for offering the best in MIGS education.
  • This year's curriculum will consist of PG Courses, Hands-on Surgical Labs, Plenary Sessions, Panels, Debates and Open Communication breakout sessions.
  • Premiering this year, AAGL is excited to introduce AAGL Talks, 15-minute TED-like presentations prior to the General Sessions, that will also provide CME credits.
  • AAGL is a professional medical association of laparoscopic surgeons and is the global leader in minimally invasive gynecologic surgery.

AAGL's Annual Global Congress Celebrates 50 Years of Excellence in Gynecologic Surgery Through Innovation and Globalization, November 14 - 17, 2021

Retrieved on: 
Monday, September 20, 2021

AAGL's congress is the premier scientific conference for gynecologic surgeons hosting thousands of attendees from around the globe.

Key Points: 
  • AAGL's congress is the premier scientific conference for gynecologic surgeons hosting thousands of attendees from around the globe.
  • Programing for AAGL's 50th Annual Global Congress centers around this year's theme of Innovation and Globalization.
  • In celebration of the 50th Annual Global Congress, AAGL has put out a call for remembrances of Congresses past.
  • AAGL is a professional medical association of laparoscopic surgeons and is the global leader in minimally invasive gynecologic surgery.